INTRODUCTION
Type I interferons (IFNab) play a major role in the innate immune defense against viral pathogens through direct inhibition of viral replication in infected cells and by regulating the survival and differentiation of key innate effector cells, such as NK cells and T and B cells of the adaptive immune system. IFNab promotes activation and maturation of antigen presenting dendritic cells (DC), facilitating the bridge between innate and adaptive immunity Kawai and Akira, 2006; Pascual et al., 2006) . IFNab production is initiated by recognition of viral components through innate sensing receptors including the Toll-like receptor (TLR) family, as well as RNA helicase and Pyrin-dependent systems (reviewed in Ware, 2005a, 2005b; Kato et al., 2006; Meylan and Tschopp, 2006; Werts et al., 2006) . Although all nucleated cells can produce IFNab in response to virus infection, plasmacytoid DC (pDC) produce high levels of IFNa in response to infection with many different viruses, utilizing largely TLR-dependent pathways Liu, 2005; Siegal et al., 1999) .
Mouse cytomegalovirus (MCMV, a b-herpesvirus) has emerged as an important model revealing host defense strategies controlling pathogen persistence and latency (Mocarski, 2004; Pollock et al., 1997; Reddehase, 2002) . Control of MCMV requires both innate and adaptive host defenses, with IFNab signaling serving as a key component of innate immunity (Orange and Biron, 1996) . MCMV replicates efficiently in most visceral organs during the first week of infection, with persistent replication in the salivary gland continuing for 4-8 weeks en route to establishing lifelong latency (Mocarski and Courcelle, 2001 ). IFNab and NK cells largely limit early replication in the spleen of C57BL/6 (B6) mice, whereas T cells are required for eventual control of acute infection and reactivation from latency. The pDC has been identified as a major IFNab-producing cell type in the spleen at times when IFNa levels have been reported to peak in the serum of B6 mice ($36 hr) (Dalod et al., 2003; Dalod et al., 2002; Krug et al., 2004) .
Evidence that pDC-derived IFNab is key for host defense to MCMV infection in vivo also comes from data indicating that mice deficient in TLR9 or MyD88 (the downstream adaptor molecule required for TLR9 signaling) show depressed levels of serum IFNab at 36 hr postinfection, and these mice are more susceptible to MCMV infection Krug et al., 2004) . TLR3 signals through the adaptor molecule TRIF, and TRIF À/À mice show increased MCMV replication, although the TLR3-TRIF pathway appears less important than TLR9 (Hoebe et al., 2003; Tabeta et al., 2004) . The lymphotoxin (LT)ab-LTb receptor signaling pathway (Schneider et al., 2004; Ware, 2005) is critical for effective host defense against MCMV Benedict et al., 2001) . Mice deficient in genes encoding LTa, LTb, and LTbR exhibit increased viral replication in the spleen and liver and increased morbidity, whereas mice deficient in LIGHT, a second ligand for the LTbR, show a modest increase in MCMV replication. The LTbR signaling pathway is thought to aid in promoting an effective IFNb response, which is linked to survival of cells of the adaptive immune system. LTa À/À mice exhibited a severe defect in the induction of IFNb mRNA in the spleen. Mice deficient in LTbR signaling also displayed a profound increase in the apoptosis of both T-and B-lymphocytes 3 to 4 days after infection with MCMV, although these cells were not directly infected. IFNab receptor deficient mice shared this lymphocyte apoptosis phenotype in response to MCMV infection implicating an important connection between the LT and IFN pathways that allows the adaptive immune system to survive MCMV infection . The LTbR pathway is critically important for the formation and homeostasis of microenvironments in lymphoid organs that promote the efficiency of the adaptive immune responses (Ehlers et al., 2003; Kabashima et al., 2005) . Recent findings suggest that MCMV's strategy of immune evasion involves targeting an LTbRdependent homeostatic pathway. LTbR signaling regulates stromal cell expression of homeostatic chemokines, such as CCL21 and CXCL13, required for trafficking and positioning of T and B cells to their respective niches in the spleen (Cyster, 2005) . Interestingly, MCMV infection selectively downregulates expression of CCL21, altering T cell positioning in the splenic white pulp (Benedict et al., 2006) . The role of the LTbR pathway in regulating the innate IFNab response presented a conundrum in view of evidence indicating that TLR-dependent pathways are important in both controlling IFNab production and for resistance to MCMV. Here, we identify a TLR-independent pathway controlling the initial IFNab response to MCMV in the spleen. This pathway involves B lymphocytes expressing LTab that crosstalk with LTbR-expressing stromal cells. MCMV preferentially infects the stromal cells in the spleen, which produce the majority of the initial IFNab. The results reveal an unorthodox strategy of the naive adaptive immune system controlling the innate host IFNab response to a viral pathogen.
RESULTS
The Type I IFN Response to MCMV in B6 Mice Is Biphasic Infection of B6 mice with MCMV induced a biphasic IFNb and IFNa response in the spleen as detected by quantitative PCR ( Figure 1A ). The initial splenic IFNb and IFNa mRNA induced by infection reached maximal accumulation by 8 hours postinfection and then declined over the next 16 hr ( Figure 1A ). At the peak response, the relative induction of mRNA was 10 4 -fold increased for IFNb and 10 5 -fold for IFNa over baseline expression in naive mice. A second, more sustained accumulation of IFNb and IFNa mRNA occurred between 36-72 hr. The IFNb mRNA levels that accumulated in the initial phase was substantially greater than achieved in the sustained phase (587 mRNA relative units/day versus 17 mRNA units/day) indicating the initial phase accounts for the majority of the IFNb transcriptional activity at these infection conditions. Expression of MCMV transcripts for immediate early (ie)-1 and 3, and the envelope glycoprotein B (gB, an early/late gene product) were readily detected in the spleen 4-8 hr postinfection ( Figure 1A ). The levels of ie1 mRNA decreased over the next 16 hr ($100-fold), paralleling the expression profile of IFNa and IFNb mRNA. In contrast, ie3 and gB mRNA remained relatively constant over the first 24 hr ( Figure 1A ). As the infection progressed, viral gene expression dramatically increased, reaching maximum abundance after two days, corresponding closely to the peak production of infectious virus, which occurs in the spleens of B6 mice 3 to 4 days postinfection (Scalzo et al., 1990) . This biphasic pattern of viral ie3 and gB mRNA expression in the spleen suggests that the initial replication cycle of MCMV was probably completed by $30-36 hr postinoculation (consistent with the replication cycle in cultured fibroblasts), followed by spread and additional rounds of virus replication over the next 2-4 days. The initial IFNab response in the -deficient mice were infected with MCMV plus or minus treatment with an agonistic anti-LTbR antibody (±aLTbR) at the time of infection. Spleens were harvested 8 hr postinfection and (A) IFNb and ie1 mRNA levels were determined by qPCR. Serum IFNa levels measured by ELISA (n = 4-6 mice per group from two independent experiments, mean ± SEM) (bottom panel spleen was proportional to the pfu in the inoculum of MCMV, as revealed by the identical ratio of IFNab mRNA to ie1 mRNA at different doses of virus ( Figure S1 ). The liver, also a major site of MCMV replication, showed a similar biphasic IFNab response, although ie1 mRNA levels remained relatively constant over the first 24 hr and increased dramatically from 2 to 4 days postinfection ( Figure 1B) . In comparison to the spleen, the accumulation of IFNb mRNA was $100-fold lower at the initial times of infection ( Figure 1B ). Serum levels of IFNa also showed a biphasic response with maximum serum levels occurring by 8-12 hr and a second peak at 48 hr concurrent with the first round of virus spread within organs. Serum IFNa was not detected during peak virus production over the 72-96 hr period ( Figure 1C ). BALB/c mice also displayed a biphasic IFNab mRNA response to MCMV infection (Figure S2 ). These data suggest that the bulk of IFNab transcriptional activity and serum IFNab response to MCMV infection occur during the initial phase.
The LTab-LTbR System Is Required for Initial IFNab Response to MCMV Infection in the Spleen Although LTa À/À mice exhibit a defect in the induction of IFNb mRNA in the spleen at 8 hr postinfection , it was not clear whether LTbR signaling was needed for both phases of the IFNab response in B6 mice. Mice deficient in both ligands for LTbR, LTb, and LIGHT (LTb/LIGHT À/À ) were used to attenuate physiological signaling while retaining the option to activate LTbR signaling using a specific agonist antibody. LTb/LIGHT À/À mice exhibited reduced IFNb mRNA levels in the spleen at 8 hr postinfection, consistent with results previously observed in LTa À/À mice (Figure 2A ). Nota-LTa À/À mice ( Figure S3 ). By contrast, hepatic expression of IFNb and ie1 mRNA in LTb/LIGHT À/À mice was comparable to wildtype B6 mice, indicating that LTbR signaling was dispensable in the liver ( Figure 2B ). Moreover, splenic IFNb and ie1 mRNA levels measured 48 hr after infection in LTb/LIGHT À/À mice were not significantly different from B6 mice ( Figure 2C ). These results indicate that LTbR-dependent signaling is required for the initial IFNab response in the spleen. Serum levels of IFNa were also dramatically reduced ($50-fold) in the LTb/LIGHT À/À -deficient mice 8 hr postinfection ( Figure 2A ) even though IFNab mRNA levels were not compromised in the liver. This result implicates the spleen as the major source of IFNab during the initial response to MCMV infection.
Administration of an agonistic anti-LTbR antibody to the LTb/ LIGHT À/À mice at the time of MCMV infection partially restored IFNb mRNA and serum IFNa ( Figure 2A ). These results indicated that the LTab/LIGHT-LTbR pathway regulates the initial IFNab response to MCMV in the spleen, but not in the liver. Furthermore, the ability of an agonist anti-LTbR mAb to partially restore the splenic IFNb response suggests that signaling through the LTbR is required during the infection to promote an optimal IFNab response.
The Initial IFNab Response to MCMV Is TLR Independent Toll-like receptor (TLR) sensing of pathogens plays a key role in innate immune defenses. Importantly, mice deficient in both TLR9 and TLR3 signaling display increased susceptibility to MCMV infection with reduced serum levels of IFNab during the sustained phase (Krug et al., 2004; Tabeta et al., 2004) . TLR9 Cpg1 mice, which are unresponsive to unmethylated CpG-oligodeoxynucleotides (Tabeta et al., 2004) , showed normal IFNab mRNA accumulation in the spleen 8 hr post-MCMV infection. Additionally, TLR9 Cpg1 had near normal levels of serum IFNa ( Figure 3A) and IFNb (data not shown) after initial infection. MCMV infection , and (C) MyD88/TRIF Lps2/Lps2
were infected with MCMV (2 3 10 5 PFU i.p.), and the IFNab, IE1, and ratio of IFNb/IE1 (3100) mRNA levels were determined by qPCR at 8 hr postinfection in the spleen; serum IFNa levels were determined by ELISA. Statistical significance (*p < 0.05) was determined using the Student's t test, and fold differences are shown in parentheses. n = 3-6 mice per group ± SEM.
of TRIF Lps2/Lps2 -deficient mice, which cannot activate the TLR3 pathway (Hoebe et al., 2003; Yamamoto et al., 2003) , resulted in a slightly higher induction of IFNb mRNA in the spleen and in serum IFNa 8 hr postinfection ( Figure 3B ). IFNa mRNA levels paralleled serum protein levels for both TLR9 Cpg1 -and TRIF Lps2/Lps2 -deficient mice (data not shown). To determine whether other TLRs might function redundantly in TLR9 Cpg1 or TRIF Lps2/Lps2 mice, mice deficient in both MyD88
and TRIF signaling pathways were infected (Figure 3C ). These mice showed no decrease in either IFNb or IFNa mRNA levels, and ie1 levels were also normal 8 hr postinfection. Taken together, these results indicate that the LTbR-dependent, initial IFNab response to MCMV in the spleen is independent of TLR signaling and suggests a specific LTab-expressing cell population promotes the initial IFNab response.
The Adaptive Immune System Promotes the Initial IFNab Response to MCMV The initial IFNab response to MCMV is rapid, suggesting that either constitutive or quickly activated LTbR signaling may be required for promoting this response. A variety of cell types including activated T cells, B-lymphocytes, and NK cells express LTb as well as DC and lymphoid tissue inducer (LTi) cells. However, naive B cells and CD4+ T cells in the spleen constitutively express LTb on their cell surface, as detected by flow cytometry ( Figure 4A ). To determine the cellular source of LTb, we analyzed MCMV in RAG À/À (which lack T-and B cells) and RAG/gc À/À mice (which, in addition, lack NK and LTi cells, due to the absence of the common g chain of the IL-2/4/7/9/15/21 receptors). Additionally, splenic DC subpopulations in RAG À/À mice are normal, while DC in RAG/gc À/À mice are skewed, with less CD4+ DC (C.D.T., unpublished data). However, both RAG À/À and RAG/gc À/À mice showed a substantial reduction in the accumulation of IFNb mRNA compared to wild-type mice ( Figure 4B ). Splenic ie1 mRNA levels in both RAG À/À and RAG/gc À/À mice at eight hr postinfection trended lower but were not statistically different from wild-type ( Figure 4B ). However, normalization of IFNb to ie1 mRNA revealed a defective initial IFNb mRNA response ($6-fold) in RAG À/À and RAG/gc À/À mice, very similar in magnitude to LTb/LIGHT À/À mice. Mice deficient in both RAG and LTbR were severely compromised in their initial IFNab response (>50-fold), which was commensurate with a substantial reduction in ie1 mRNA levels ($6-fold). However, the IFNb/ie1 mRNA ratio revealed a comparable, viral ''dose-dependent''
IFNab defect to that seen in both RAG À/À and LTb/LIGHT À/À mice ( Figure 4B ). Serum IFNa levels in RAG À/À , RAG/gc À/À , and RAG/LTbR À/À mice during the initial response to MCMV were undetectable by the ELISA ( Figure 4B ).
B Cells Expressing LTb Are Required for the Initial IFNab Response to MCMV
The results observed in RAG À/À mice raised the possibility that naive T and/or B cells provide the stimulus for the initial IFNab response to MCMV infection, either directly or indirectly. As both T and B lymphocytes lack expression of LTbR, it is likely that lymphocytes deliver the ligand to LTbR-expressing cells. To delineate which of these lymphocyte populations were the responsible subset, mice genetically deficient in either B cells (Igh-6À/À), CD4 + (Cd4À/À), or CD8 + T lymphocytes (b2mÀ/À) were infected with MCMV. B cell-deficient mice showed a 4-fold reduction in Spleens were harvested 8 hr postinfection and IFNb and ie1 mRNA levels were determined by qPCR and normalized to the levels of 18S rRNA (top two panels of both [B] and [C] ). IFNb/ie1 mRNA ratio (3100) was calculated and serum IFNa levels were determined by ELISA; ND, not detectable) (two lower panels). Statistical significance (*p < 0.05) was determined using the Student's t test, and fold differences are shown in parentheses. n = 4-6 mice per group ± SEM.
IFNb mRNA at 8 hr post-MCMV infection and a drastic reduction in serum IFNa ( Figure 4C ). In contrast, neither CD4 T cell nor CD8 T cell-deficient mice showed a reduction in splenic IFNb mRNA or serum IFNa ( Figure 4C ). The expression level of ie1 mRNA was similar in all groups tested. To directly test whether the lack of LTb expression by B cells was responsible for the compromised initial IFNab response to MCMV, mice conditionally deficient in ltb in Bor (B-LTb) or T cells (T-LTb) were utilized (Tumanov et al., 2003) . Strikingly, B-LTb mice, but not T-LTb mice, displayed a dramatic reduction in IFNb (7-fold) and IFNa mRNA (12-fold) ( Figure 5) . B-LTb-deficient mice also showed $3-fold reduction in ie1 mRNA in the spleen that when normalized to ie1 mRNA yielded an $5-fold decrease in IFNab mRNA, a result virtually identical to that seen in mice lacking the entire B lymphocyte compartment or deficient in LTb/LIGHT. Taken together, this result highlights the critical importance of LTb expressed in B cells to promote the initial IFNab response to MCMV infection.
LTbR-Expressing Stromal Cells Produce the Initial IFNab during MCMV Infection via a NIK-Dependent Pathway
The identification of B-lymphocytes as the critical, LTbexpressing cells promoting the initial IFNab response to MCMV in the spleen was surprising given that naive B cells are not infected by MCMV and lack expression of the LTbR (Force et al., 1996) . To determine whether the hematopoietic or radio-resistant stromal compartments require expression of the LTbR, bone marrow chimeric mice were generated between LTbR À/À or wild-type mice. LTbR À/À recipients reconstituted with wild-type B6 bone marrow (B6/LTbR) exhibited reduced IFNb mRNA accumulation ($10-fold) when compared to wild-type controls (B6/B6) at 8 hr postinfection ( Figure 6A ). This IFNb deficiency was comparable to that seen in mice defective for LTbR expression in both cellular compartments (LTbR/LTbR). In contrast, wild-type mice that received LTbR-deficient bone marrow (LTbR/B6) produced normal levels of IFNb mRNA. Thus, stromal cells require expression of LTbR to mount the initial IFNab response to MCMV ( Figure 6A) .
Separation of the spleen into stroma and hematopoietic fractions revealed that IFNb and IFNa mRNA were 25-to 30-fold enriched in the stromal cell fraction from mice infected for 8 hr with MCMV ( Figure 6B ). Moreover, viral ie1 mRNA expression also preferentially localized to the stromal compartment ($15-fold enriched) consistent with previous immunohistochemical (Benedict et al., 2006) and electron microscopy studies (Mercer et al., 1988 ) that stromal cells are the major site of MCMV infection in the spleen. Together, these results indicate that radioresistant stromal cells expressing the LTbR are both the target of initial infection and the major producer of IFNab in response to MCMV.
LTbR activation of the NF-kB pathway requires the activity of the NF-kB-inducing kinase (NIK) (Dejardin et al., 2002; Basak et al., 2007) , and LTbR-mediated, canonical NF-kB signaling is also dependent upon NIK (Basak et al., 2007) . To test whether NIK is required for the initial IFNab response in the splenic stroma, aly/aly mice (functional mutation in NIK) (Xiao et al., 2001) were infected with MCMV. Strikingly, aly/aly mice showed a reduction in both IFNb and IFNa mRNA at 8 hr postinfection ($26-and 104-fold, respectively), with a commensurate reduction in ie1 mRNA ($11-fold).
Discussion
The type I Interferon response is a key contributor to successful host defense against viral pathogens, such as MCMV Dalod et al., 2002; Salazar-Mather et al., 2002) . Here, we define the cellular interactions required to initiate the earliest innate IFNab response to a b-herpesvirus. In response to MCMV, the LTab-LTbR pathway is required for the induction of IFNab in the spleen, which constitutes a major source of initial IFNab production. Our results reveal that B-lymphocytes provide the source of LTb required to promote the initial innate IFNab response in LTbR-expressing stromal cells, and it is cells in the stromal compartment that are both infected and producers of IFNab during MCMV infection. Induction of initial IFNab mRNA and protein regulated by the LTbR pathway is independent of TLR-signaling pathways, indicating that a significant difference exists in the molecular mechanisms promoting the initial and sustained phases of the IFNab response to MCMV infection. Together, the results reveal a frontline innate host defense strategy directed by B cells of the adaptive immune system communicating with stromal cells via the LTab-LTbR system. Spleens were harvested 8 hr postinfection and the IFNb, IFNa, and ie1 mRNA levels were detected by qPCR and normalized to 18S rRNA. The ratio of IFNb/ie1 mRNA (3100) is shown. Serum IFNa levels were determined by ELISA. Statistical significance (*p < 0.05) was determined using the Student's t test, and fold differences are shown in parentheses. n = 4-6 mice per group; average of two independent experiments ± SEM.
The biphasic pattern of IFNab induction in the spleen and liver reflects the initial host response to the primary inoculum, with the subsequent sustained phase resulting from the secondary response to viral spread and continued cycles of replication at later times. The initial IFNab mRNA response to MCMV peaked at 8 hr, paralleled by a rise in serum IFNa, rapidly declined and was followed by sustained expression for the next few days. The accumulated peak of IFNb mRNA levels indicated the bulk of the IFNab transcriptional activity occurred during the initial phase of the infection, and the magnitude of the response in the spleen was substantially higher than in the liver. In addition, the level of IFNa in the serum, reflecting accumulation from all tissue sources, was dramatically reduced in the LTb/LIGHT À/À -deficient mice, despite an uncompromised IFNab mRNA response in the liver. This evidence, together with the relative abundance of IFNab mRNA in the spleen, supports the idea that the LTbR pathway regulates the major source of type I IFN during MCMV infection.
Our results and those of others indicate that TLR-dependent defense pathways control IFNab expression in response to MCMV during the later, sustained phase. This conclusion is based on the uncompromised IFNab response to MCMV during the initial phase in TLR9 CpG , Trif Lps2/Lps2 , and MyD88/TRIF Lps2/Lps2 mice. The complexity of the sustained phase of the IFNab response is apparent from studies showing TLR, MyD88, and plasmacytoid DC are important at 36 hr post-MCMV infection (Andoniou et al., 2005; Delale et al., 2005; Krug et al., 2004; Tabeta et al., 2004) , but additional results indicate their influence may decline at 44 hr postinfection (Andoniou et al., 2005; Delale et al., 2005; Krug et al., 2004) . These data further support the idea that the initial IFNab response regulated by the LTbR pathway is distinct from the TLR-dependent pathways functioning in plasmacytoid DC. These results indicate the LTab-IFN axis is an independent mechanism from conventional paradigms in which myeloid lineage cells largely promote innate defenses to pathogens. Additionally, that LTb/LIGHT À/À mice fail to control acute MCMV replication in both the spleen and liver at 72 hr postinfection Additionally, although dendritic cell subpopulations are altered in the spleen LTbR/B6 bone marrow chimeric mice (Kabashima et al., 2005; De Trez et al., 2008) , the initial IFNab response to MCMV was normal in these mice. Finally, although LTb/ LIGHT À/À mice lack both marginal zone and marginal metallophillic macrophage populations, they mount a normal IFNab response to MCMV at 48 hr, and our studies in LTbR/B6 mice indicate LTbR expression by these macrophages is not required for the initial response. Together, these results indicate that alterations in myeloid cell subsets or the lymphatic vasculature are not likely to account for the reduced initial IFNab production in LTb/ LIGHT À/À mice. Moreover, the partial restoration of the IFNb mRNA response in LTb/LIGHT À/À mice treated with an agonist anti-LTbR indicates that LTbR signaling contributes during the virus infection to induce IFNb. The limited effect of acutely deliv- (3100) is shown in the bottom panel. Statistical significance (*p < 0.05) was determined using the Student's t test comparing each experimental group with the B6/B6 control mice, and the fold difference is shown in parentheses. n = 3-5 mice per group ± SEM. (B) Stromal cells from MCMV (2 3 10 5 PFU i.v.) infected spleens (pooled from 5 infected mice) were separated from hematopoietic cells (see Experimental Procedures). Total cell RNA was then isolated from either the stromal or hematopoietic cell fractions, and qPCR was performed to determine IFNb, IFNa, and ie1 mRNA levels. (C) aly/aly mice or wildtype littermate controls (n = 4) were infected with MCMV, and spleens were analyzed by qPCR for IFNab and ie1 mRNA levels at 8 hr postinfection. Infection conditions and data analysis is identical to that in (A).
ered anti-LTbR suggests that differentiative effects on stromal cells may be necessary (Drayton et al., 2004) to fully restore the IFNab response. The agonist LTbR antibody may also enhance the regulation of cellular trafficking across the high endothelial venules, which is regulated by LTbR signaling, perhaps increasing the initial dissemination of MCMV to the spleen from the peritoneal cavity (Browning et al., 2005; Drayton et al., 2003) . Strikingly, the bone marrow chimeric mice indicated that LTbexpressing B cells exclusively communicate with, or regulate the differentiation of, LTbR expressing stromal cells, which produce the majority (>95%) of the IFNab and IE1 mRNA following MCMV infection. Along these lines, a role for constitutively expressed LTb by B cells in regulating the microarchitecture of the spleen was recently shown to play an important role in containing VSV and LCMV infection (Junt et al., 2006) . LTab is exclusively positioned in the membrane indicating the conversation between B cells and stromal cells occurs through direct cell contact. The radioresistant stromal compartment includes many distinct cell types that could be infected, including endothelial cells, myocytes, and fibroblasts in addition to specialized parenchymal cells identified by specific chemokine expression, such as CXCL13 (Cyster, 2003) . The exact lineage of stromal cells infected by MCMV in the spleen is currently unknown.
The importance of this B cell-stromal cell interaction is evident in LT deficient mice, which are highly susceptible to infection with MCMV (for review see Ware, 2005) . Increased morbidity occurs in LTa-, LTb-, or LTbR-deficient mice or wild-type mice treated with LTbR-Fc decoy in response to MCMV Benedict et al., 2001) . Mice deficient in IFNab receptor phenocopy LT-deficient mice, which undergo massive apoptosis of T and B lymphocytes during infection that are not directly infected by the virus . LTbR expression was required in both the hematopoietic and stromal compartments of the spleen to completely protect against this apoptosis induced by MCMV, implicating crosstalk occurs between the myeloid and stromal compartments to induce IFNab and promote survival of lymphocytes . Our results in aly/aly mice strongly indicate this LT-dependent crosstalk requires NIK, likely involving activation of NF-kB, a known key player in the regulation of IFNb transcription (Thanos and Maniatis, 1995) . Together, these results indicate that the initial B cell directed IFNab response contributes to viral control, and ultimately helps to promote the survival of the adaptive immune response.
B lymphocytes play a critical role in the post natal maturation and homeostasis of the splenic microarchitecture, a structural feature designed to promote highly efficient immune responses (Cupedo et al., 2004) . LTab-LTbR signaling pathway is required to form the marginal zone, wherein antigen-capturing macrophages, B cells and dendritic cells reside (Kraal, 1992) and regulate expression of the lymphoid tissue chemokines (CCL21, CXCL13) in specialized stromal cells creating discrete microniches that compartmentalize T cells to the periarteriole region surrounded by the B cell follicles (Cyster, 2003) . MCMV targets the splenic microarchitecture by specifically suppressing expression of CCL21 mRNA, evident two to three days after infection (Benedict et al., 2006) . The specific loss of CCL21 leaves T cells without sufficient cues to localize around the arteriole. However, MCMV did not significantly alter the B cell follicle chemokine CXCL13, unlike infection with lymphocytic choriomeningitis virus, which reduces expression of both these splenic chemokines (Mueller et al., 2007) suggesting the LT-IFN pathway might protect the B cell micro-niche during MCMV infection.
The commitment of genomic information encoding resistance to MCMV (estimated at 1%-3% of the host genome) suggests herpesviruses provide powerful selective pressures for diversification of host resistance mechanisms (Beutler et al., 2005) . Likewise, the accumulation of numerous immune modulating mechanisms in the viral genome, many derived from ''captured'' cellular genes, indicates a long coevolutionary history. That two distinct human herpesviruses, HSV-1 and HCMV, target receptors (HVEM and BTLA) involved in LT-dependent signaling, underscores this coevolutionary relationship (Cheung et al., 2005) . Indeed, resistance to other pathogens is provided to the host as a consequence of infection with either g-and b-herpesviruses, suggesting a strong symbiotic relationship has emerged from the host-virus interplay (Barton et al., 2007) . In the context of evolution, the LTab-LTbR pathway, functioning as a developmental and homeostatic regulator, may have evolved as an adaptive countermeasure to promote an early IFN response in the cells initially infected by the virus, perhaps in response to the functional paralysis of macrophages and DC by MCMV (Andrews et al., 2001; Popkin et al., 2003) . The discovery of this B cell-dependent pathway also suggests an unrecognized route to IFNab production that may operate in autoimmune diseases, such as lupus erythematosus, where both infection and genetic factors contribute to pathogenesis (Baccala et al., 2007) . (Scheu et al., 2002) and LTbRÀ/À (Futterer et al., 1998) were backcrossed five generations (n = 5) to B6 mice. LTa À/À mice were generated as described (De Togni et al., 1994) and were obtained from Jackson Labs. LTbRÀ/À mice were crossed onto RAG1À/À (C57BL/6) mice at LIAI. The conditional LTb-deficient mice were derived by breeding LTb ''floxed'' mice with CD19-Cre knockin mice for the B cell-specific deletion, and CD4-Cre transgenic mice were used for T cell-specific deletion (Tumanov et al., 2003) . TLR9 CpG1 mice and Trif Lps2/Lps2 mice generated on the C57BL/6 background by ENU mutagenesis were obtained from Dr. Bruce Beutler (Hoebe et al., 2003; Tabeta et al., 2004) . MyD88/TRIF Lps2/Lps2 doubly deficient mice were obtained from Dr. Sujan Shresta, (constructed by Dr. S. Akira and Dr. B. Beutler). All mice were used at 6-12 weeks and were age and sex matched. Mice were treated with the agonist rat anti-mouse LTbR at 100 mg injected i.p. at the time of infection. For bone marrow transplantation, recipient mice were lethally irradiated (1000 rad) and reconstituted with total donor bone marrow cells (10 7 cells/ recipient mouse) by injection into the retro-orbital sinus of the recipients; recipient mice were given antibiotics in the drinking water for 3 weeks. The chimeric mice were analyzed 7 weeks post transfer; recipient mice were analyzed with CD45 allelic markers (LTbRÀ/À CD45.2 or B6 CD45.1) to verify reconstitution.
Virus
Mouse CMV (Smith strain) was prepared from salivary glands from infected BALB/c mice as described previously (Benedict et al., 2001 ). Preparations were derived from a virus stock acquired from the ATCC (VR-1399) that was propagated twice through mouse salivary glands for amplification/generation of a ''seed stock.'' This seed stock was then used to infect mice to generate viral stocks for use in all experiments. In addition, all stocks were centrifuged through a 20% sorbitol cushion and resuspended in PBS. The infectious virus in the preparation was quantified by plaque assay on NIH 3T3 cells (Reddehase et al., 1985) . All breeding and experimental protocols were performed under the approval by LIAI Animal Care Committee.
Quantitative PCR Gene expression was assayed by quantitative RT-PCR (Stratagene Mx4000), as described (Benedict et al., 2001) . Total cellular RNA was isolated from snap frozen tissues using the TRIzol reagent and purified with RNeasy Mini RNA purification kit (QIAGEN, Chatsworth, CA). RNA was treated with DNaseI and 2 mg were used for the RT reaction. The primers for detection of murine IFNb, IFNa and the MCMV immediate early genes IE1, IE3 and late gene gB were: IFNb, rRNA in individual samples, except in one case where L32 was used. IFNa primers were designed to hybridize to a region of the IFNa mRNA that is 100% conserved in 13/14 murine IFNa subtypes. Real-time PCR data was analyzed using the Relative Expression Software Tool (REST) for groupwise comparison and statistical analysis of relative gene expression (Pfaffl et al., 2002) and with Prism Software (Student's pairwise t test).
Interferon ELISA IFNa and IFNb serum levels were quantified using ELISA that detects mouse IFN-aA, a1, a4, a5, a6, and a9. Briefly, plates coated with a rat anti-mouse IFNa mAb (RMMA-1, PBL Biomedical Laboratories) were incubated with serum samples, followed by rabbit anti-mouse IFNa polyclonal Ab (PBL Biomedical Laboratories), and horseradish peroxidase-conjugated goat anti-rabbit IgG for detection (Jackson ImmunoReaserch Laboratories) with the substrate TMB (eBioscience). Recombinant IFNa (PBL Biomedical Laboratories) was used to generate a standard curve (12.5-500pg/ml). Colorimetric changes of enzyme substrates were detected at 450 nm (SpectraMax, Molecular Devices) and data analyzed with the SOFTmax Pro software.
Cell Host & Microbe
LTab-Induced IFNab during Initial MCMV Infection
Separation of Splenic Stroma and Hematopoietic Cells
Spleens from mice infected for 8 hours with 2 3 10 5 PFU of MCMV were separated into a stroma and hematopoietic fractions, RNA extracted for Real Time PCR analysis as previously described (Benedict et al., 2006) . Briefly, spleens were perfused with collagenase (100 U/ml) in Hanks' Balanced Salt Solution containing Ca 2+ and Mg 2 for 30 min at 37 C. Treated spleens from five mice were then pooled and extruded through a 70 mm nylon filter strainer in order to obtain sufficient amounts of stromal cell RNA. Cells extruded through the filter (hematopoietic fraction) and cells retained on filter (stromal fraction) were washed with PBS followed by lysis with Trizol. The filter-bound stromal fraction from uninfected mice contained a maximum of 15%-30% contaminating hematopoietic cells, and 4%-7% contaminating stromal cells in the hematopoietic fraction based on marker genes expressed exclusively in the hematopoietic (CD80, IL-7Ra, LTa, and LTb) and stromal (gp38 and IL-7) compartments.
Flow Cytometry
Single cell suspensions of splenic leukocytes were preincubated with antiFcgRII/III blocking reagent (2.4G2; BD PharMingen). Cell surface LTb was detected with monoclonal antibody BB.F6.F6.BF2 (BD PharMingen) followed by biotinylated goat anti-hamster IgG and Streptavidin APC. For the lymphocyte subset detection the following antibodies from BD were used: PE 145-2C11 (anti-CD3), FITC RM4-4 (anti-CD4), FITC 53-6.7 (anti-CD8), and PE RA3-6B2 (anti-B220). Stained cells were analyzed on a FACSCalibur flow cytometer using CellQuest research software (BD Biosciences) and FlowJo Software.
Supplemental Data
The Supplemental Data include three supplemental figures and can be found with this article online at http://www.cellhostandmicrobe.com/cgi/content/full/ 3/2/67/DC1/.
